Development of Engineered Native Bacteria as a Tool for Functional Manipulation of the Gut Microbiome
开发工程原生细菌作为肠道微生物组功能操纵的工具
基本信息
- 批准号:10737475
- 负责人:
- 金额:$ 78.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-20 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAntibioticsBackBacteriaBacteroidesBasic ScienceBiologicalChronic DiseaseClinicalCommunicable DiseasesCommunitiesDataDevelopmentDiseaseEcologyEngineeringEngraftmentEnvironmentEscherichia coliFunctional disorderGene ExpressionGeneticGnotobioticGoalsHealthHumanImmune System DiseasesIndividualIntestinesKnock-inKnowledgeLactobacillusLearningMediatingMissionModificationMusNational Institute of Allergy and Infectious DiseaseNutrientOrganismOutcomePathologicPathologyPhenotypePhysiologicalPhysiological ProcessesPhysiologyProductionProtein SecretionProteinsPublic HealthReportingResearchResearch PersonnelRoleSignal TransductionSourceSystemTestingTherapeuticTransgenescombatcostcurative treatmentsdesigngut microbiomegut microbiotahost-microbe interactionsimprovedin vivoin vivo Modelinnovationinterestmetabolomicsmicrobial communitymicrobial hostmicrobiomemicrobiome compositionmicrobiome researchmicrobiome therapeuticsmicroorganismnovel strategiespatient stratificationpreventquorum sensingreal world applicationrisk stratificationsynthetic biologytargeted treatmenttechnology developmenttooltool developmenttransgene deliverytransgene expressiontranslational impact
项目摘要
PROJECT SUMMARY/ABSTRACT
Most therapies that target microbiome composition do not have a detectable impact on the gut microbiome
and are not robust to the interpersonal diversity and plasticity of the community in human hosts. To develop a
better mechanistic understanding of the microbe-host relationship and more effective microbiome-mediated
therapies, approaches based on functional modulation of the gut microbiome are necessary. However, these
approaches have been difficult to develop. Attaining long-term engraftment in the luminal environment has
proven to be quite difficult, and even once engraftment has been achieved, a change in physiology or
improvement of pathologic phenotype has not yet been demonstrated. There is a critical need for a tool that will
allow investigators to “knock-in” functions into the gut microbiome and investigate their effects on the luminal
milieu and, ultimately, physiology in conventionally-raised hosts in non-sterile conditions. The investigators
propose a novel approach to address this need by using native bacteria as chassis for the introduction of specific
functions into the luminal environment. The proposal's innovation is a new strategy that allows the quick and
effective “knock-in” of a beneficial function in a sustained manner into conventional hosts. To date they have
demonstrated that tractable native bacteria can be engineered to express a beneficial function ex vivo,
reintroduced to the host, engraft the entire gut of the host, and deliver an intended beneficial function. These
functions can affect host physiology, help determine the effect of specific bacterial functions and potentially
alleviate disease. The central hypothesis of this proposal is that long-term colonization and functional change in
the gut microbiome of a conventional host can be performed effectively with engineered native bacteria.
In the next five years, the investigators will continue the development of this technology and better
understand the chassis-host interactions that will aid in the development of live bacterial therapeutics for clinical
use. First, the investigators will engineer regulatory systems for the transgene of interest, including a sense and
control, protein secretion, and biocontainment circuit. They will test whether these systems function in vivo in
hosts that are in a non-sterile environment. In addition, they will assess the natural biocontainment of engineered
native bacteria among co-housed hosts. Second, they will determine how the niche for a bacterial chassis affects
function delivery and whether multiple functions can be delivered by the same chassis or whether different
chassis are necessary for the delivery of multiple functions. Finally, the investigators will determine the role of
microbial community in amplifying the effects of a transgene of interest in gnotobiotic mice. The expected
outcome of the proposed studies is attainment of fundamental biological knowledge of how the gut microbiome
can be functionally manipulated. These studies will have a positive translational impact because they will
demonstrate that synthetic biology approaches can lead to the development of curative interventions to some of
the most debilitating and costly chronic diseases.
PROJECT SUMMARY/ABSTRACT
Most therapies that target microbiome composition do not have a detectable impact on the gut microbiome
and are not robust to the interpersonal diversity and plasticity of the community in human hosts. To develop a
better mechanistic understanding of the microbe-host relationship and more effective microbiome-mediated
therapies, approaches based on functional modulation of the gut microbiome are necessary. However, these
approaches have been difficult to develop. Attaining long-term engraftment in the luminal environment has
proven to be quite difficult, and even once engraftment has been achieved, a change in physiology or
improvement of pathologic phenotype has not yet been demonstrated. There is a critical need for a tool that will
allow investigators to “knock-in” functions into the gut microbiome and investigate their effects on the luminal
milieu and, ultimately, physiology in conventionally-raised hosts in non-sterile conditions. The investigators
propose a novel approach to address this need by using native bacteria as chassis for the introduction of specific
functions into the luminal environment. The proposal's innovation is a new strategy that allows the quick and
effective “knock-in” of a beneficial function in a sustained manner into conventional hosts. To date they have
demonstrated that tractable native bacteria can be engineered to express a beneficial function ex vivo,
reintroduced to the host, engraft the entire gut of the host, and deliver an intended beneficial function. These
functions can affect host physiology, help determine the effect of specific bacterial functions and potentially
alleviate disease. The central hypothesis of this proposal is that long-term colonization and functional change in
the gut microbiome of a conventional host can be performed effectively with engineered native bacteria.
In the next five years, the investigators will continue the development of this technology and better
understand the chassis-host interactions that will aid in the development of live bacterial therapeutics for clinical
use. First, the investigators will engineer regulatory systems for the transgene of interest, including a sense and
control, protein secretion, and biocontainment circuit. They will test whether these systems function in vivo in
hosts that are in a non-sterile environment. In addition, they will assess the natural biocontainment of engineered
native bacteria among co-housed hosts. Second, they will determine how the niche for a bacterial chassis affects
function delivery and whether multiple functions can be delivered by the same chassis or whether different
chassis are necessary for the delivery of multiple functions. Finally, the investigators will determine the role of
microbial community in amplifying the effects of a transgene of interest in gnotobiotic mice. The expected
outcome of the proposed studies is attainment of fundamental biological knowledge of how the gut microbiome
can be functionally manipulated. These studies will have a positive translational impact because they will
demonstrate that synthetic biology approaches can lead to the development of curative interventions to some of
the most debilitating and costly chronic diseases.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFF M HASTY其他文献
JEFF M HASTY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFF M HASTY', 18)}}的其他基金
Reprogramming cell-fate decisions through predictive modeling and synthetic biology
通过预测模型和合成生物学重新编程细胞命运决定
- 批准号:
10784558 - 财政年份:2022
- 资助金额:
$ 78.86万 - 项目类别:
Reprogramming cell-fate decisions through predictive modeling and synthetic biology
通过预测模型和合成生物学重新编程细胞命运决定
- 批准号:
10344041 - 财政年份:2022
- 资助金额:
$ 78.86万 - 项目类别:
Reprogramming cell-fate decisions through predictive modeling and synthetic biology
通过预测模型和合成生物学重新编程细胞命运决定
- 批准号:
10706965 - 财政年份:2022
- 资助金额:
$ 78.86万 - 项目类别:
Reprogramming cell-fate decisions through predictive modeling and synthetic biology
通过预测模型和合成生物学重新编程细胞命运决定
- 批准号:
10908026 - 财政年份:2022
- 资助金额:
$ 78.86万 - 项目类别:
Design and characterization of bacterial population dynamics in solid tumor models
实体瘤模型中细菌种群动态的设计和表征
- 批准号:
10212134 - 财政年份:2021
- 资助金额:
$ 78.86万 - 项目类别:
Design and characterization of bacterial population dynamics in solid tumor models
实体瘤模型中细菌种群动态的设计和表征
- 批准号:
10456087 - 财政年份:2021
- 资助金额:
$ 78.86万 - 项目类别:
A microbiome-informed platform for the development and testing of bacterial therapies for colorectal cancer
用于开发和测试结直肠癌细菌疗法的微生物组信息平台
- 批准号:
10166805 - 财政年份:2020
- 资助金额:
$ 78.86万 - 项目类别:
A microbiome-informed platform for the development and testing of bacterial therapies for colorectal cancer
用于开发和测试结直肠癌细菌疗法的微生物组信息平台
- 批准号:
9974305 - 财政年份:2020
- 资助金额:
$ 78.86万 - 项目类别:
A microbiome-informed platform for the development and testing of bacterial therapies for colorectal cancer
用于开发和测试结直肠癌细菌疗法的微生物组信息平台
- 批准号:
10397153 - 财政年份:2020
- 资助金额:
$ 78.86万 - 项目类别:
A microbiome-informed platform for the development and testing of bacterial therapies for colorectal cancer
用于开发和测试结直肠癌细菌疗法的微生物组信息平台
- 批准号:
10631898 - 财政年份:2020
- 资助金额:
$ 78.86万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 78.86万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 78.86万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 78.86万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 78.86万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 78.86万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 78.86万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 78.86万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 78.86万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 78.86万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 78.86万 - 项目类别:
Research Grant